Daniel Holden

1.8k total citations · 1 hit paper
30 papers, 1.0k citations indexed

About

Daniel Holden is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Daniel Holden has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 19 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Daniel Holden's work include Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Daniel Holden is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Daniel Holden collaborates with scholars based in United States, China and Germany. Daniel Holden's co-authors include Richard E. Carson, Nabeel Nabulsi, Yiyun Huang, Shu-fei Lin, Joël Mercier, Jonas Hannestad, Sjoerd J. Finnema, Evan Baum, David Matuskey and Ming-Kai Chen and has published in prestigious journals such as Biological Psychiatry, Science Translational Medicine and Psychopharmacology.

In The Last Decade

Daniel Holden

30 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Imaging synaptic density in the living human brain

2016 361 citations Sjoerd J. Finnema, Nabeel Nabulsi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Holden United States	15	499	337	251	232	218	30	1.0k
Dai Fukumoto Japan	27	503 1.0×	401 1.2×	178 0.7×	170 0.7×	275 1.3×	45	1.5k
Joerg Neddens Germany	19	742 1.5×	603 1.8×	327 1.3×	273 1.2×	67 0.3×	46	1.4k
Chie Seki Japan	20	312 0.6×	303 0.9×	219 0.9×	160 0.7×	391 1.8×	101	1.2k
Hiroyuki Ohba Japan	25	733 1.5×	602 1.8×	161 0.6×	198 0.9×	331 1.5×	71	1.7k
Geoffrey L. Curran United States	12	450 0.9×	336 1.0×	536 2.1×	148 0.6×	340 1.6×	12	1.3k
Takuya Toyonaga United States	21	644 1.3×	292 0.9×	595 2.4×	385 1.7×	544 2.5×	95	1.8k
Roni Dhaher United States	11	320 0.6×	178 0.5×	136 0.5×	142 0.6×	101 0.5×	16	641
Olivier Barret United States	25	460 0.9×	514 1.5×	458 1.8×	170 0.7×	445 2.0×	82	1.7k
Julie Keelan United Kingdom	9	464 0.9×	519 1.5×	231 0.9×	109 0.5×	318 1.5×	12	1.2k
Francisco R. Lopez‐Picon Finland	18	340 0.7×	283 0.8×	302 1.2×	62 0.3×	100 0.5×	47	904

Countries citing papers authored by Daniel Holden

Since Specialization

Citations

This map shows the geographic impact of Daniel Holden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Holden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Holden more than expected).

Fields of papers citing papers by Daniel Holden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Holden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Holden. The network helps show where Daniel Holden may publish in the future.

Co-authorship network of co-authors of Daniel Holden

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Holden. A scholar is included among the top collaborators of Daniel Holden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Holden. Daniel Holden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gu, Jiwei, Ming‐Qiang Zheng, Daniel Holden, et al.. (2025). PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [18F]TZ4877 in Nonhuman Primates. Molecular Imaging and Biology. 27(1). 54–63. 2 indexed citations

Smart, Kelly, Ming‐Qiang Zheng, Daniel Holden, et al.. (2023). In Vivo Imaging and Kinetic Modeling of Novel Glycogen Synthase Kinase-3 Radiotracers [11C]OCM-44 and [18F]OCM-50 in Non-Human Primates. Pharmaceuticals. 16(2). 194–194. 6 indexed citations

Datta, Dibyadeep, Feng Liang, Nicolas R. Barthélemy, et al.. (2023). Chronic GCPII (glutamate‐carboxypeptidase‐II) inhibition reduces pT217Tau levels in the entorhinal and dorsolateral prefrontal cortices of aged macaques. Alzheimer s & Dementia Translational Research & Clinical Interventions. 9(4). e12431–e12431. 8 indexed citations

Zheng, Ming‐Qiang, Kelly Smart, Yuping Xu, et al.. (2022). Characterization in nonhuman primates of (R)-[18F]OF-Me-NB1 and (S)-[18F]OF-Me-NB1 for imaging the GluN2B subunits of the NMDA receptor. European Journal of Nuclear Medicine and Molecular Imaging. 49(7). 2153–2162. 4 indexed citations

Groman, Stephanie M., Ansel T. Hillmer, Krista Fowles, et al.. (2020). Midbrain D3 Receptor Availability Predicts Escalation in Cocaine Self-administration. Biological Psychiatry. 88(10). 767–776. 15 indexed citations

Groman, Stephanie M., Ansel T. Hillmer, Krista Fowles, et al.. (2020). Dysregulation of Decision Making Related to Metabotropic Glutamate 5, but Not Midbrain D3, Receptor Availability Following Cocaine Self-administration in Rats. Biological Psychiatry. 88(10). 777–787. 12 indexed citations

Lew, Robert, Cristian Constantinescu, Daniel Holden, et al.. (2020). The rate of dasotraline brain entry is slow following intravenous administration. Psychopharmacology. 237(11). 3435–3446. 2 indexed citations

Bini, Jason, Daniel Holden, Kathryn Fontaine, et al.. (2020). Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand 11C-UCB-J. EJNMMI Research. 10(1). 83–83. 9 indexed citations

Nabulsi, Nabeel, Daniel Holden, Ming‐Qiang Zheng, et al.. (2019). Evaluation of¹¹C-LSN3172176 as a Novel PET Tracer for Imaging M₁Muscarinic Acetylcholine Receptors in Nonhuman Primates. Journal of Nuclear Medicine. 60(8). 1147–1153. 16 indexed citations

10.

Li, Songye, Zhengxin Cai, Wenjie Zhang, et al.. (2019). Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A). European Journal of Nuclear Medicine and Molecular Imaging. 46(9). 1952–1965. 37 indexed citations

11.

Sandiego, Christine, Olivier Barret, Hsiaoju Lee, et al.. (2019). Imaging histamine H3 receptors with [¹⁸F]FMH3: Test–retest and occupancy studies in the non‐human primate. Synapse. 73(7). e22096–e22096. 1 indexed citations

12.

Baum, Evan, Zhengxin Cai, Frédéric Y. Bois, et al.. (2017). PET Imaging Evaluation of Four σ₁ Radiotracers in Nonhuman Primates. Journal of Nuclear Medicine. 58(6). 982–988. 21 indexed citations

13.

Hillmer, Ansel T., Songye Li, Ming‐Qiang Zheng, et al.. (2017). PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans. European Journal of Nuclear Medicine and Molecular Imaging. 44(6). 1042–1050. 40 indexed citations

14.

Hillmer, Ansel T., Daniel Holden, Krista Fowles, et al.. (2017). Microglial depletion and activation: A [11C]PBR28 PET study in nonhuman primates. EJNMMI Research. 7(1). 59–59. 42 indexed citations

15.

Nabulsi, Nabeel, Joël Mercier, Daniel Holden, et al.. (2016). Synthesis and Preclinical Evaluation of¹¹C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain. Journal of Nuclear Medicine. 57(5). 777–784. 194 indexed citations

16.

Finnema, Sjoerd J., Tore Eid, Mingkai Chen, et al.. (2016). 11C-UCB-J as a biomarker for synaptic density - an in vivo/in vitro validation study. 57. 1800–1800. 1 indexed citations

17.

Tavares, Adriana, Fabien Caillé, Olivier Barret, et al.. (2014). Whole-body biodistribution and dosimetry estimates of a novel radiotracer for imaging of serotonin 4 receptors in brain: [18F]MNI-698. Nuclear Medicine and Biology. 41(5). 432–439. 10 indexed citations

18.

Parker, Christine A., Nabeel Nabulsi, Daniel Holden, et al.. (2014). Evaluation of ¹¹C-BU99008, a PET Ligand for the Imidazoline₂ Binding Sites in Rhesus Brain. Journal of Nuclear Medicine. 55(5). 838–844. 39 indexed citations

19.

Zheng, Ming‐Qiang, Su Jin Kim, Daniel Holden, et al.. (2014). An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of¹¹C-LY2459989. Journal of Nuclear Medicine. 55(7). 1185–1191. 24 indexed citations

20.

Roberts, Brooke M., Daniel Holden, Christopher L. Shaffer, et al.. (2010). Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction. Behavioural Brain Research. 212(1). 41–48. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact